JOSEPH WANZEK: Open Payments
NPI 1164538674 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,024 in 157 payments from 32 companies in 2025. Trend: 2023 $2,051 · 2024 $2,880 · 2025 $3,024
Food & beverage: $2,933Education: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $592 |
| AstraZeneca Pharmaceuticals LP | 14 | $410 |
| Lilly USA, LLC | 13 | $212 |
| PFIZER INC. | 14 | $208 |
| Lundbeck LLC | 11 | $206 |
| Novo Nordisk Inc | 10 | $190 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $103 |
| Actelion Pharmaceuticals US, Inc. | 1 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
Products named: REXULTI, VRAYLAR, FARXIGA, QULIPTA, MOUNJARO, UBRELVY, Ozempic, NURTEC ODT.
Industry payments across IA — which companies pay providers there.
